ROBERT HOFFMAN Insider Trading $KTRA Kintara Therapeutics, Inc.
Get free email notifications about insider trading for ROBERT HOFFMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HOFFMAN. ROBERT HOFFMAN is CFO & SVP, Finance in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and CFO & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and SVP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in CombiMatrix Corp ($CBMX) and CHIEF FINANCIAL OFFICER in INNOVUS PHARMACEUTICALS, INC. ($INNV) and Director in Kura Oncology, Inc. ($KURA) and Director in DelMar Pharmaceuticals, Inc. ($DMPI) and Director in Aravive, Inc. ($VSAR).
ROBERT HOFFMAN in Kintara Therapeutics, Inc.
Trading Symbol: KTRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: Director
Holdings: 0 shares
Latest Transaction: Sep 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT HOFFMAN in Kintara Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, ARNA, CBMX, HRTX, INNV, KTRA, KURA, MBVX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 17 2020 | DMPI | Kintara Therapeuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 1.70 | 120,000 | 204,000 | 120,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 39,567 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 40,000 | 24,396 | 40,000 | |
Apr 17 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Apr 17 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 1.06 | 36,000 | 38,160 | 36,000 |
Page: 1